Navigation Links
HemoShear Relocates and Expands Operations to Historic Martha Jefferson Property in Charlottesville, Virginia
Date:1/22/2013

CHARLOTTESVILLE, Va., Jan. 22, 2013 /PRNewswire/ -- HemoShear LLC, a biotechnology research company and leading developer of human-relevant systems for drug development and discovery, today announced that it will expand and relocate its operations to downtown Charlottesville, Virginia.  The Company will initially lease 14,800 square feet of the Cardwell Building in the historic former Martha Jefferson Hospital, now owned by Octagon Partners.  The lease allows for expansion to additional floors, as HemoShear's business requires.

(Logo: http://photos.prnewswire.com/prnh/20120416/PH86899LOGO)

HemoShear has grown to more than 30 employees since launching operations in 2009.  The Company continues to expand its customer base, which includes most major biopharmaceutical companies, by deploying its human-relevant systems and scientific expertise to reduce new drug R&D costs and improve success rates of new drug candidates. In 2012, HemoShear received the Rocket Award from the Charlottesville Business Innovation Council for rapid commercialization of a new technology.  

The renovated Cardwell space will allow for continued growth as HemoShear increases the scope of its pharmaceutical customer partnerships and its technology development.  Nicole Hastings , Ph.D., Vice President of Operations, said, "The Cardwell Building has an ideal infrastructure. The new space allows us to design for improved workflow, optimal productivity and quality.  We are also excited to be located near all of the downtown Charlottesville activities and to contribute to the growth of the Charlottesville bioscience community."

Demolition for the new space is underway and HemoShear is actively planning for its move to the Cardwell Building in mid-2013.  Mark Mascotte of MFM Partners, LLC, represented the landlord in the lease transaction.  StellarOne Bank and the Commonwealth of Virginia provided financial assistance to HemoShear. Local contractor Vision Building & Design, LLC will perform the demolition, design and space outfit. 

About HemoShear LLC 
HemoShear creates human-relevant systems that accurately replicate the biology of organ systems and diseases for drug discovery and development. Working in strategic partnerships with pharmaceutical, biotechnology and medical device companies, HemoShear generates meaningful data to increase confidence in decision-making, reduce risk of costly failures and identify efficacious therapies.  HemoShear's science leads to new medicines and improves human health.  

 


'/>"/>
SOURCE HemoShear LLC
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. HemoShear Adds Industry Veterans Mehmood Khan and Fred Brown to Board of Managers
2. HemoShear Unveils In Vitro Steatosis System at Annual Meeting of the Association for the Study of Liver Diseases
3. HemoShear Publishes Key Review on Human-Relevant Organotypic Systems
4. Sysmex America Relocates Corporate Headquarters
5. ImmusanT Relocates Offices to State-of-the-Art Innovation Facility
6. Ultragenyx Relocates Company Headquarters to Support Operational Expansion
7. AAIPharma Expands Laboratory Service Offerings and Capabilities in its Technology Center
8. Concentra Expands Medical Services within the Dallas-Fort Worth area
9. AssureRx Health Expands Management Team to Support Increasing Business Growth
10. Cumberland Emerging Technologies Expands Life Sciences Center
11. VWR International, LLC Expands European Portfolio With Acquisitions Of Labonord SAS And Switch BVBA
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/29/2016)... Calif. , April 29, 2016  In ... is projected to shift from systems dependent on ... all types of modality CRT Medical monitors and ... there are a host of foreseeable benefits to ... concern; will existing modalities have to be replaced ...
(Date:4/29/2016)... 2016 ReportsnReports.com adds "Pulmonary ... research report that provides an overview of the ... various stages, therapeutics assessment by drug target, mechanism ... molecule type, along with latest updates, and featured ... players involved in the therapeutic development for Pulmonary ...
(Date:4/29/2016)... April 29, 2016 Acquisition ... Sciences, Product Development Capabilities in North ... Base . Indegene ( http://www.indegene.com ... the acquisition of Skura Corporation,s life science business. ... adaptive sales enablement technology for life science organizations ...
Breaking Medicine Technology:
(Date:4/29/2016)... Hills, CA (PRWEB) , ... April 29, 2016 , ... ... of devices and products for the head and neck/ear, nose and throat specialty, has ... Device , The KOTLER NASAL AIRWAY™ is a newly patented safety device ...
(Date:4/29/2016)... ... April 29, 2016 , ... ... growth round of funding led by Eastside Partners, with participation from existing investor ... growing customer base and accelerate its technology and product roadmap. , ...
(Date:4/29/2016)... ... April 29, 2016 , ... Regenerative Medicine Solutions (RMS) scored 94.8124 ... survey, earning them second place for Tampa’s Best Places to Work. They were ranked ... is a great accomplishment for our team,” says RMS Human Resources Manager Irene Miller. ...
(Date:4/29/2016)... ... April 29, 2016 , ... The infertility specialists at HRC Fertility/Orange County (HRC/OC) ... Daniel A. Potter -- are proud of the recent release of their 2014 in ... SART published the latest verified data for 375 U.S. member clinics. *Preliminary ...
(Date:4/29/2016)... ... April 29, 2016 , ... Natren, Inc. recently sent representatives ... Petbiotics ™, as they fondly call them. As animal lovers, they were ... their non-profit organizations. Animal rescues across the nation face huge hurdles rescuing animals ...
Breaking Medicine News(10 mins):